Metraipolis › archive › dc_2d259df4a3e2

A tumor immune microenvironment gene expression signature for predicting prognosis, immunotherapy efficacy, and drug candidates in triple-negative breast cancer — Europe PMC PMID:41293150

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41293150
DOI
10.3389/fimmu.2025.1676768
License (as archived)
solo-consultazione
Archived
2026-11-08T16:45:00.559Z
SHA-256 of the archived text
afc56f20a6f2a23b5c57985eb31eb7b513bdc516573d4dbb8ed3fe63ae724d2f
Stable URL of this page
https://metraipolis.com/documento/dc_2d259df4a3e2

How to cite

A tumor immune microenvironment gene expression signature for predicting prognosis, immunotherapy efficacy, and drug candidates in triple-negative breast cancer — Europe PMC PMID:41293150 — Europe PMC (en), https://europepmc.org/article/MED/41293150 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2d259df4a3e2 (Metraipolis archive dc_2d259df4a3e2, sha256 afc56f20a6f2a23b5c57985eb31eb7b513bdc516573d4dbb8ed3fe63ae724d2f)
BibTeX
@misc{dc2d259df4a3e2,
  title = {A tumor immune microenvironment gene expression signature for predicting prognosis, immunotherapy efficacy, and drug candidates in triple-negative breast cancer — Europe PMC PMID:41293150},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41293150},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2d259df4a3e2; sha256 afc56f20a6f2a23b5c57985eb31eb7b513bdc516573d4dbb8ed3fe63ae724d2f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41293150. Agents can read the archived copy with the MCP tool read_document.